ID

37714

Descripción

18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET/CT) For The Evaluation Of Response To Therapy In Bone-Dominant Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02110160

Link

https://clinicaltrials.gov/show/NCT02110160

Palabras clave

Versiones (1)
  1. 19/8/19 19/8/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

19 de agosto de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Bone Dominant Metastatic ER+ Breast Cancer NCT02110160

Inglés

Eligibility Bone Dominant Metastatic ER+ Breast Cancer NCT02110160

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, at least 18 years of age, with a history of pathologically confirmed er+ breast cancer
Descripción

Adult | Age | Oestrogen receptor positive breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
UMLS CUI [3]
C2938924
biopsy proven or clinically obvious documented bone metastases from breast cancer (with the majority of the disease burden in the bone)
Descripción

Secondary malignant neoplasm of bone From Breast Carcinoma | Secondary malignant neoplasm of bone Predominant

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0153690
UMLS CUI [1,2]
C1517320
UMLS CUI [1,3]
C0678222
UMLS CUI [2,1]
C0153690
UMLS CUI [2,2]
C1542147
patients planning to start new endocrine targeted therapy (any line of therapy is acceptable and any endocrine therapy is allowed)
Descripción

Endocrine Therapy Planned

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C1301732
willing and able to comply with scheduled visits and serial imaging procedures
Descripción

Compliance Visits Scheduled | Compliance Imaging Procedures Repeated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0008952
UMLS CUI [1,3]
C0205539
UMLS CUI [2,1]
C1321605
UMLS CUI [2,2]
C0079595
UMLS CUI [2,3]
C0205341
agrees to allow access to clinical records regarding response to treatment and long term follow up 6. be informed of the investigational nature of this study and provide written informed consent in accordance with institutional and federal guidelines.
Descripción

Access Medical Records allowing | Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0444454
UMLS CUI [1,2]
C0025102
UMLS CUI [1,3]
C0683607
UMLS CUI [2]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
women who are pregnant or breast feeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
uncontrolled diabetes mellitus (fasting glucose greater than 200 mg/dl)
Descripción

DIABETES MELLITUS UNCONTROLLED | Glucose measurement, fasting

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0743131
UMLS CUI [2]
C0202045
inability to tolerate imaging procedures (e.g. claustrophobia, severe pain)
Descripción

Imaging procedures Receive Unable | Claustrophobia | Severe pain

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0079595
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C1299582
UMLS CUI [2]
C0008909
UMLS CUI [3]
C0278140
weight exceeding capacity of imaging table
Descripción

Body Weight Inappropriate Imaging procedure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005910
UMLS CUI [1,2]
C1548788
UMLS CUI [1,3]
C0079595
previous treatment with radiation or surgery to a significant percentage of bony metastatic sites 6. treatment with marrow stimulating agents (e.g. granulocyte colony stimulating factor (gcsf)) within 3 weeks of baseline scan
Descripción

Prior radiation therapy Metastatic cancer site Bony | Operative Surgical Procedure Metastatic cancer site Bony | Pharmaceutical Preparations Bone Marrow Stimulation | Granulocyte Colony-Stimulating Factor

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0279134
UMLS CUI [1,2]
C0280457
UMLS CUI [1,3]
C0443157
UMLS CUI [2,1]
C0543467
UMLS CUI [2,2]
C0280457
UMLS CUI [2,3]
C0443157
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0005953
UMLS CUI [3,3]
C1292856
UMLS CUI [4]
C0079459
Volver a la parte superior de la página

Similar models

Eligibility Bone Dominant Metastatic ER+ Breast Cancer NCT02110160

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age | Oestrogen receptor positive breast cancer
Item
adult patients, at least 18 years of age, with a history of pathologically confirmed er+ breast cancer
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C2938924 (UMLS CUI [3])
Secondary malignant neoplasm of bone From Breast Carcinoma | Secondary malignant neoplasm of bone Predominant
Item
biopsy proven or clinically obvious documented bone metastases from breast cancer (with the majority of the disease burden in the bone)
boolean
C0153690 (UMLS CUI [1,1])
C1517320 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C0153690 (UMLS CUI [2,1])
C1542147 (UMLS CUI [2,2])
Endocrine Therapy Planned
Item
patients planning to start new endocrine targeted therapy (any line of therapy is acceptable and any endocrine therapy is allowed)
boolean
C0279025 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Compliance Visits Scheduled | Compliance Imaging Procedures Repeated
Item
willing and able to comply with scheduled visits and serial imaging procedures
boolean
C1321605 (UMLS CUI [1,1])
C0008952 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C1321605 (UMLS CUI [2,1])
C0079595 (UMLS CUI [2,2])
C0205341 (UMLS CUI [2,3])
Access Medical Records allowing | Informed Consent
Item
agrees to allow access to clinical records regarding response to treatment and long term follow up 6. be informed of the investigational nature of this study and provide written informed consent in accordance with institutional and federal guidelines.
boolean
C0444454 (UMLS CUI [1,1])
C0025102 (UMLS CUI [1,2])
C0683607 (UMLS CUI [1,3])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
women who are pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
DIABETES MELLITUS UNCONTROLLED | Glucose measurement, fasting
Item
uncontrolled diabetes mellitus (fasting glucose greater than 200 mg/dl)
boolean
C0743131 (UMLS CUI [1])
C0202045 (UMLS CUI [2])
Imaging procedures Receive Unable | Claustrophobia | Severe pain
Item
inability to tolerate imaging procedures (e.g. claustrophobia, severe pain)
boolean
C0079595 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0008909 (UMLS CUI [2])
C0278140 (UMLS CUI [3])
Body Weight Inappropriate Imaging procedure
Item
weight exceeding capacity of imaging table
boolean
C0005910 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C0079595 (UMLS CUI [1,3])
Prior radiation therapy Metastatic cancer site Bony | Operative Surgical Procedure Metastatic cancer site Bony | Pharmaceutical Preparations Bone Marrow Stimulation | Granulocyte Colony-Stimulating Factor
Item
previous treatment with radiation or surgery to a significant percentage of bony metastatic sites 6. treatment with marrow stimulating agents (e.g. granulocyte colony stimulating factor (gcsf)) within 3 weeks of baseline scan
boolean
C0279134 (UMLS CUI [1,1])
C0280457 (UMLS CUI [1,2])
C0443157 (UMLS CUI [1,3])
C0543467 (UMLS CUI [2,1])
C0280457 (UMLS CUI [2,2])
C0443157 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C0005953 (UMLS CUI [3,2])
C1292856 (UMLS CUI [3,3])
C0079459 (UMLS CUI [4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial